Physical Deteriorations in Allo-HSCT.

Status Completed

Clinical Trial Summary

Limited number of studies reported impairments in physical activity, exercise capacity and quality of life of allogeneic hematopoietic stem cell transplantation (allogeneic-HSCT) recipients. However, comparison of dyspnea, exercise capacity, physical activity level and quality of life in allogeneic-HSCT recipients versus age-gender matched healthy individuals have not been known so far.To compare dyspnea, submaximal exercise capacity, physical activity level and quality of life in allogeneic-HSCT recipients with healthy individuals.

Clinical Trial Description

Hematopoietic stem cell transplantation (HSCT) is a prevalent curative treatment approach for a large variety of diseases affecting hematopoietic systems. More than 50.000 HSCT are implemented all over the world annually. Despite having complex aspect, allogeneic-HSCT also serves as an important chance of survival and cure for patients with hematological malignancies. Allogeneic-HSCT recipients have at least 2-year survival rate, yet long term complications such as chronic health conditions, life-threatening diseases, musculoskeletal and cardiopulmonary disorders may occur in recipients following HSCT due to general state of immunosuppression and medications. Besides pulmonary complications existed in 30-50% of HSCT recipients, pulmonary infiltrates especially after allogeneic HSCT is an ongoing challenge for recipients. All toxic treatments received to cure hematological malignancies including HSCT and various complications seen after HSCT may induce muscle weakness, decreased submaximal exercise capacity and oxygen consumption via impaired skeletal muscle oxygenation in most allogeneic-HSCT long-term survivors. Therefore, European Society for Blood and Marrow Transplantation Group recommends that allied health-care professionals should take part in team for a successful dynamic process of allogeneic-HSCT.

Limited number of studies reported impairments in exercise capacity, physical activity and quality of life in allogeneic-HSCT recipients. However it is not known that to what extent dyspnea, exercise capacity, physical activity and quality of life impair in allogeneic recipients who were over 100 days status post transplantation versus age-gender matched healthy individuals so far. Therefore aspiration of current study was comparison of dyspnea, submaximal exercise capacity, physical activity level and quality of life in allogeneic-HSCT recipients with healthy individuals. ;

Study Design

Related Conditions & MeSH terms

Stem Cell Transplantation

Clinical Trial Details

NCT number	NCT03606005
Study type	Observational
Source	Gazi University
Contact
Status	Completed
Phase
Start date	March 2012
Completion date	October 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03918343` - Lipopolysaccharide Metabolism and Identification of Potential Biomarkers Predictive of Graft-versus-host Disease After Allogeneic Stem Cell Transplantation	N/A
Not yet recruiting	`NCT05438823` - Technology Supported Education Program Based on Human Care Theory	N/A
Not yet recruiting	`NCT02193399` - Physiotherapy in Hematopoietic Stem Cell Transplantation	N/A
Withdrawn	`NCT00972101` - Infusion of Expanded Cord Blood T Cells	Phase 1
Completed	`NCT05421299` - A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate
Completed	`NCT04976933` - Post-HSCT Medication Adherence mHealth App
Completed	`NCT04798495` - Feasibility of a Rehabilitation Programme Targeted Patients Treated With Non-myeloablative Stem Cell Transplantation	N/A
Completed	`NCT00612274` - Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation	Phase 0
Active, not recruiting	`NCT04511130` - Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant	Phase 2
Recruiting	`NCT05968963` - Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation	N/A
Recruiting	`NCT02940093` - Pipeline Integrating Gut Metagenome Data, Host Immunogenetic Characteristics and Clinical Gut Inflammatory Biomarkers	N/A
Not yet recruiting	`NCT06077734` - Muscle Stem Cell Quality in Atrophy
Terminated	`NCT00587990` - Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS)	Phase 1/Phase 2
Terminated	`NCT00597441` - Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus Transplantation	Phase 1
Active, not recruiting	`NCT03684083` - Inflammatory Response to Paramyxovirus Infection in an Ex-vivo Model of Bronchial Epithelial Cells in Allogeneic HSCT Recipients
Recruiting	`NCT00884338` - Cognitive Function After Stem Cell Transplantation	Phase 3
Completed	`NCT00284713` - Progenitor Cell Therapy in Dilative Cardiomyopathy	Phase 1/Phase 2
Withdrawn	`NCT00062543` - Hepatic Artery Infusion of CD34+ Cells	Phase 1
Completed	`NCT00781170` - Dose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma	Phase 2
Recruiting	`NCT03364257` - iDTECT Blood Performance for the Identification of Viral or Bacterial Pathogens in Febrile Neutropenic Patients